Walleye Capital’s Hims & Hers Health HIMS Stock Holding History

Walleye Capital’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.86M	Sell	140,100 -3,100	-2%	-$83.2K	0.02%	844
2026 Q1	$2.97M	Sell	143,200 -403,600	-74%	-$9.53M	0.01%	1151
2025 Q4	$17.8M	Buy	546,800 +314,300	+135%	+$13.5M	0.05%	344
2025 Q3	$13.2M	Buy	232,500 +119,800	+106%	+$6.14M	0.05%	413
2025 Q2	$5.62M	Buy	112,700 +29,300	+35%	+$1.32M	0.02%	808
2025 Q1	$2.46M	Sell	83,400 -90,100	-52%	-$3.35M	0.01%	1275
2024 Q4	$4.2M	Buy	173,500 +72,500	+72%	+$1.8M	0.01%	1200
2024 Q3	$1.86M	Sell	101,000 -8,900	-8%	-$159K	﹤0.01%	2028
2024 Q2	$2.22M	Buy	109,900 +69,700	+173%	+$1.16M	﹤0.01%	2006
2024 Q1	$622K	Buy	40,200 +32,700	+436%	+$369K	﹤0.01%	3009
2023 Q4	$66.8K	Buy	7,500 +6,400	+582%	+$47.3K	﹤0.01%	4216
2023 Q3	$6.92K	Hold	1,100	–	–	﹤0.01%	4538
2023 Q2	$10.3K	Buy	+1,100	New	+$10.9K	﹤0.01%	3906

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Walleye Capital's HIMS Position: Q2 2026 in Review

Walleye Capital reduced its Hims & Hers Health (HIMS) stake by 92% in Q2 2026, selling an estimated $8.08M and leaving 24,878 shares worth $863K. The position accounts for ﹤0.01% of the portfolio, ranked #2254.

Walleye Capital first reported a position in HIMS in Q1 2020 and has held it in 20 quarters since. The position peaked at $12.3M in Q4 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Walleye Capital held 24,878 shares of Hims & Hers Health worth $863K as of Q2 2026.
Walleye Capital sold 300,875 Hims & Hers Health shares in Q2 2026, an estimated $8.08M.
Hims & Hers Health made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #2254 holding.
Walleye Capital first reported a position in Hims & Hers Health in Q1 2020 and has held it in 20 quarters since.
Walleye Capital's Hims & Hers Health position peaked at $12.3M in Q4 2025.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.